Planning your research protocol? This calculator helps estimate how often a compound should be administered based on its half-life and your desired daily dosage.
How to use:
Select your SARM compound
Enter a target daily dose (mg)
Get a suggested dosing interval based on known half-life data
Use this tool to optimize consistency in compound exposure during your study timeframe.
For research guidance only. Not medical advice. Based on in-vivo usage.
If you’ve spent any time in the SARMs world, you’ve probably seen the same debate pop up everywhere: As research study conductors, or potential candidates in approved trials, it’s important to understand the liver health concerns related to SARMs. “Are SARMs toxic to the liver?” Some people say they’re perfectly safe; others claim they cause …
The truth about why we don’t stock GW501516 – and why you should be cautious if you see it elsewhere. What is Cardarine? Cardarine (GW501516) is a PPARδ receptor agonist originally developed for metabolic and cardiovascular research. It was never approved for human use and was discontinued during preclinical trials. So why isn’t it sold …
Enclomiphene citrate isn’t just “clomid without the estrogen baggage.” Its pharmacokinetics – how the body absorbs, distributes, metabolizes, and eliminates it – are the real reason it behaves so differently from clomiphene in both men and women. If you’re using Enclomiphene for testosterone recovery, secondary hypogonadism, or fertility support, understanding these kinetics is what separates predictable outcomes from hormonal chaos. Let’s …
Overview Ostarine – often referred to as MK-2866 or Enobosarm – is a Selective Androgen Receptor Modulator (SARM) developed by GTx, Inc. for conditions like muscle wasting and osteoporosis. “Ostarine represents one of the most clinically advanced SARMs, with multiple Phase II trials conducted in cancer-related cachexia and age-related sarcopenia.” – Journal of Cachexia, Sarcopenia and …
Hurry while stocks last! Use code PAYDAY15 at checkout to get 15% off sitewide. Valid for
Join the WaitlistWe will inform you when the product is back in stock. Enter your email address below.
SARMs Research Dose & Half-Life Calculator
Planning your research protocol? This calculator helps estimate how often a compound should be administered based on its half-life and your desired daily dosage.
How to use:
Use this tool to optimize consistency in compound exposure during your study timeframe.
For research guidance only. Not medical advice. Based on in-vivo usage.
SARMs Dose & Half-Life Calculator
Related Posts
Are SARMs Hard on Your Liver? A Research-Focused Breakdown
If you’ve spent any time in the SARMs world, you’ve probably seen the same debate pop up everywhere: As research study conductors, or potential candidates in approved trials, it’s important to understand the liver health concerns related to SARMs. “Are SARMs toxic to the liver?” Some people say they’re perfectly safe; others claim they cause …
Why isn’t Cardarine (GW501516) available?
The truth about why we don’t stock GW501516 – and why you should be cautious if you see it elsewhere. What is Cardarine? Cardarine (GW501516) is a PPARδ receptor agonist originally developed for metabolic and cardiovascular research. It was never approved for human use and was discontinued during preclinical trials. So why isn’t it sold …
What you need to know about Enclomiphene’s Pharmacokinetics
Enclomiphene citrate isn’t just “clomid without the estrogen baggage.” Its pharmacokinetics – how the body absorbs, distributes, metabolizes, and eliminates it – are the real reason it behaves so differently from clomiphene in both men and women. If you’re using Enclomiphene for testosterone recovery, secondary hypogonadism, or fertility support, understanding these kinetics is what separates predictable outcomes from hormonal chaos. Let’s …
What is Ostarine (MK-2866)? A Complete Guide for UK Researchers in 2025
Overview Ostarine – often referred to as MK-2866 or Enobosarm – is a Selective Androgen Receptor Modulator (SARM) developed by GTx, Inc. for conditions like muscle wasting and osteoporosis. “Ostarine represents one of the most clinically advanced SARMs, with multiple Phase II trials conducted in cancer-related cachexia and age-related sarcopenia.” – Journal of Cachexia, Sarcopenia and …